Research indicates that the activation status of the renin-angiotensin-aldosterone system (RAAS) undergoes alterations in Type 1 and Type 2 diabetes mellitus (T1DM/T2DM) patients with various complications [12–14]. This evidence concerns the gene REN and diabetes mellitus.